Day One, September 12, 2024 - MT (Mexican Pacific Time, GMT-07:00)
Day One, September 12, 2024 - MT (Mexican Pacific Time, GMT-07:00)
- Missie Scheffman - Region Director Reimbursement, West, Astellas
- Callie Mertel - Senior Conference Producer, Informa Connect
As the technology available for hub programs continues to rapidly evolve, take a look at
specific case studies on the tools and innovations that can be used to ease provider workflow and optimize patient outcome.
- Understand the role that disease state, as well as patient population and location, has on technology selection or the lack thereof
- Learn the importance of your technology being able to pivot throughout the hub lifecycle
Kickstart the Congress with a panel discussion comprised of top industry executives working with the hub space. Engage in a comparison of experiences, best practices and benchmarking across companies of varying size and maturity.
- Josh Konetzni - Senior Vice President, Head of Business Development, VMS BioMarketing
- Marla Hogle - Manager, Patient Support Services, Dexcom
- Discuss best practices in selecting an effective partner for your hub
- Understand what makes a partnership successful, specifically for a new product or single asset company
- Uncover common partnership gaps and how to catch in advance as you look at the RFP process
- Ensure that your partnership is a solid extension of your own brand to increase it’s longevity
- Jennifer Clark - Senior Director, Patient Services, Menarini Stemline
- Tony Soto - Director, Patient Services, Sumitomo Pharma America
- Learn more about free drug, bridge and startup programs and how they can be best managed within a hub
- Understand how to integrate patient assistance within your program
- Highlight the main risks and OIG watchouts to compliantly build free drug programs
- Heather Schaefer - Senior Director, Patient Services Enterprise Strategy, Takeda Pharmaceuticals, Inc.
While integrated specialty pharmacy services are not new, they are becoming a more popular model of care as the number of complex care treatments on the market continues to increase.
- Learn more about the technologies and systems that medically integrated specialty pharmacies (MIPs) use to improve efficiency and patient outcome
- Uncover the benefits MIPs provide for healthcare practices, patients and costs by allowing for real-time access to patient medical records, labs and notes, and easier access to prescribing clinicians
- Learn how MIPs allow for more holistic and focused patient support
As the intricacies surrounding patient access become more complex, so have the compliance challenges faced by manufacturers.
- Understand the importance of robust data and an effective vendor partnership in remaining compliant
- Learn the necessity behind compliance, marketing and commercial teams working together to conduct due diligence on the hub and the specific activities that are involved in doing so
- Navigate evolving regulations/enforcement activity and new patient access-related needs to mitigate risk and remain compliant
- Sharon Delshad - Director, Legal Affairs, Corporate and Compliance Counsel, Travere Therapeutics
The choice between insourced hubs, outsourced solutions, or a strategic combination of both is a critical decision for companies seeking operational excellence. This session provides a comprehensive exploration of the key considerations surrounding insourced and hybrid hubs
- Explore advantages and challenges associated with insourced and hybrid models
- Understand strategies for achieving cost optimization through insourcing or hybrid solutions, balancing the benefits of in-house control with potential cost savings
- Examine the adaptability and flexibility afforded by insourced and hybrid hubs
- Discover the role of technology in optimizing insourced and hybrid hubs
- Naveed Masood - Head of US Launch Readiness and Patient Services, Servier
- Vanessa Padua - Director, Patient Support Services, Cytokinetics